Key Facts on the Cannabis Industry
The global cannabis market is projected to reach $1.4 trillion by 2034, rising from approximately $138 billion in 2023. This growth is driven by increasing legalization and access to medical and recreational marijuana products, indicating a compound annual growth rate of over 34%.
In a significant development, the U.S. government has rescheduled FDA-approved marijuana products from Schedule I to Schedule III, marking a crucial milestone for the industry. This change hints at potential future reforms, possibly paving the way for broader legalization.
Investment in cannabis stocks, such as Tilray Brands (NASDAQ: TLRY), carries inherent risks. While Tilray continues to face financial challenges, the anticipation of legalization drives its market value. Other operators like Curaleaf Holdings and Trulieve Cannabis are also noted as players that may benefit from these regulatory changes in the U.S.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
